BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22290709)

  • 1. 1H NMR-based metabonomic applications to decipher gut microbial metabolic influence on mammalian health.
    Martin FP; Collino S; Rezzi S
    Magn Reson Chem; 2011 Dec; 49 Suppl 1():S47-54. PubMed ID: 22290709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic applications to decipher gut microbial metabolic influence in health and disease.
    Martin FP; Collino S; Rezzi S; Kochhar S
    Front Physiol; 2012; 3():113. PubMed ID: 22557976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary modulation of gut functional ecology studied by fecal metabonomics.
    Martin FP; Sprenger N; Montoliu I; Rezzi S; Kochhar S; Nicholson JK
    J Proteome Res; 2010 Oct; 9(10):5284-95. PubMed ID: 20806900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Panorganismal gut microbiome-host metabolic crosstalk.
    Martin FP; Sprenger N; Yap IK; Wang Y; Bibiloni R; Rochat F; Rezzi S; Cherbut C; Kochhar S; Lindon JC; Holmes E; Nicholson JK
    J Proteome Res; 2009 Apr; 8(4):2090-105. PubMed ID: 19281268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes.
    Xie G; Zhang S; Zheng X; Jia W
    Electrophoresis; 2013 Oct; 34(19):2787-98. PubMed ID: 23775228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemometric strategy for modeling metabolic biological space along the gastrointestinal tract and assessing microbial influences.
    Martin FP; Montoliu I; Kochhar S; Rezzi S
    Anal Chem; 2010 Dec; 82(23):9803-11. PubMed ID: 21033673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutrimetabonomics:applications for nutritional sciences, with specific reference to gut microbial interactions.
    Claus SP; Swann JR
    Annu Rev Food Sci Technol; 2013; 4():381-99. PubMed ID: 23297777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of NMR-based metabolomics to the study of gut microbiota in obesity.
    Calvani R; Brasili E; Praticò G; Sciubba F; Roselli M; Finamore A; Marini F; Marzetti E; Miccheli A
    J Clin Gastroenterol; 2014; 48 Suppl 1():S5-7. PubMed ID: 25291128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant components of the Thoroughbred metabolome characterised by (1) H-nuclear magnetic resonance spectroscopy: A metabolite atlas of common biofluids.
    Escalona EE; Leng J; Dona AC; Merrifield CA; Holmes E; Proudman CJ; Swann JR
    Equine Vet J; 2015 Nov; 47(6):721-30. PubMed ID: 25130591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking the gut microbiota to human health.
    Robles Alonso V; Guarner F
    Br J Nutr; 2013 Jan; 109 Suppl 2():S21-6. PubMed ID: 23360877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems biology of host-microbe metabolomics.
    Heinken A; Thiele I
    Wiley Interdiscip Rev Syst Biol Med; 2015; 7(4):195-219. PubMed ID: 25929487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating effects of penicillin treatment on the metabolome of rats.
    Sun J; Schnackenberg LK; Khare S; Yang X; Greenhaw J; Salminen W; Mendrick DL; Beger RD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():134-43. PubMed ID: 23831706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR-based metabonomics analysis of mouse urine and fecal extracts following oral treatment with the broad-spectrum antibiotic enrofloxacin (Baytril).
    Romick-Rosendale LE; Goodpaster AM; Hanwright PJ; Patel NB; Wheeler ET; Chona DL; Kennedy MA
    Magn Reson Chem; 2009 Dec; 47 Suppl 1():S36-46. PubMed ID: 19768747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances and perspectives in in vitro human gut fermentation modeling.
    Payne AN; Zihler A; Chassard C; Lacroix C
    Trends Biotechnol; 2012 Jan; 30(1):17-25. PubMed ID: 21764163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring healthy metabolic trajectories with nutritional metabonomics.
    Collino S; Martin FP; Kochhar S; Rezzi S
    Nutrients; 2009 Jan; 1(1):101-10. PubMed ID: 22253970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
    Esteve E; Ricart W; Fernández-Real JM
    Curr Opin Clin Nutr Metab Care; 2011 Sep; 14(5):483-90. PubMed ID: 21681087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse.
    Yap IK; Li JV; Saric J; Martin FP; Davies H; Wang Y; Wilson ID; Nicholson JK; Utzinger J; Marchesi JR; Holmes E
    J Proteome Res; 2008 Sep; 7(9):3718-28. PubMed ID: 18698804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics.
    Lindon JC; Nicholson JK
    Annu Rev Anal Chem (Palo Alto Calif); 2008; 1():45-69. PubMed ID: 20636074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota.
    Cani PD; Delzenne NM
    Curr Opin Pharmacol; 2009 Dec; 9(6):737-43. PubMed ID: 19628432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.